• Relative Versus Fractional Viability in Cancer Drug Testing

  2026-08-11

  Hannah Schwartz’s dissertation shows that relative viability and fractional viability capture different components of anticancer drug response: proliferative arrest and cell killing. Its central practical contribution is a framework for interpreting both response magnitude and timing, improving how tumor cell growth inhibition is evaluated in vitro.

• SCP4, H3T3 Dephosphorylation, and Chromosome Stability

  2026-08-11

  The reference study identifies SCP4 as a nuclear phosphatase that removes mitotic H3T3 phosphorylation and helps control chromosomal passenger complex recruitment. Cell-based and mouse-zygote evidence connects disrupted SCP4 activity with chromosome missegregation, aneuploidy, and early embryonic mitotic failure.

• Acetylspiramycin: From Structure to Assay Design

  2026-08-10

  Acetylspiramycin (Spiramycin B) is more than a 50S-directed macrolide: its chemical identity, biosynthetic context, and solvent behavior directly shape experimental interpretation. This guide connects ribosomal pharmacology with assay controls, resistance research, and immune-model design.

• SP2509: Lysine-Specific Demethylase 1 Antagonist

  2026-08-09

  SP2509 enables selective interrogation of LSD1-driven chromatin regulation in acute myeloid leukemia models, connecting H3K4 methylation changes with differentiation, apoptosis, and colony suppression. This workflow-focused guide covers assay design, combination studies, solubility control, and how lessons from BRD4-RAC1 research can strengthen epigenetic experiments without overstating cross-cancer evidence.

• Aprotinin Workflows for Protease-Controlled Research

  2026-08-08

  Aprotinin provides reversible control of trypsin, plasmin, and kallikrein in biochemical, inflammatory, and cardiovascular research workflows. This guide also shows how the reference study’s cost-efficient GRO-seq design can inform protease-controlled sample handling without confusing an exploratory additive with a validated sequencing reagent.

• Amplex Red H2O2 Assay Workflow

  2026-08-07

  Amplex Red converts otherwise non-fluorescent peroxide signals into a sensitive resorufin readout for enzyme, cell-based, and oxidative stress studies. A SOD-aware workflow makes the assay especially useful when NADPH or NADH can generate peroxide-related background through HRP.

• CLK2 Inhibition as a Strategy to Overcome Platinum Resistanc

  2026-08-07

  Jiang et al. elucidate how Cdc2-like kinase 2 (CLK2) promotes platinum resistance in ovarian cancer by enhancing DNA repair via BRCA1 phosphorylation. Their mechanistic findings highlight CLK2 as a promising target for alternative splicing modulation and therapeutic intervention in difficult-to-treat ovarian tumors.

• Advances in Small-Molecule Activation of Human Mitochondrial

  2026-08-06

  Recent work by Shu et al. provides a comprehensive analysis of small-molecule strategies for selectively activating human mitochondrial serine protease ClpP (hClpP), with a focus on structure–activity relationships and anticancer applications. Their synthesis of design principles and pharmacological data offers a foundation for translational research targeting mitochondrial proteostasis and metabolism.

• ARCA Cy5 EGFP mRNA (5-moUTP): Redefining Precision in mRNA D

  2026-08-06

  Explore how ARCA Cy5 EGFP mRNA (5-moUTP) leverages 5-methoxyuridine modification and advanced fluorescent labeling for unmatched mRNA localization and translation efficiency assays. This article uniquely analyzes product-specific advantages and translates recent nanoparticle delivery innovations into practical assay decisions.

• Pcbp1 Regulates Mitochondrial Integrity for Antibody Product

  2026-08-05

  Zhu et al. identify the RNA-binding protein Pcbp1 as a critical regulator of mitochondrial function and protein synthesis in B cells, directly linking posttranscriptional control to antibody production and germinal center responses. Their mechanistic work clarifies how mitochondrial integrity, mediated via Fdxr mRNA regulation, supports humoral immunity and provides a foundation for targeted investigation of B cell metabolism.

• Dual-Action Kinase Inhibitors Accelerate p38α MAPK Dephospho

  2026-08-05

  The reference study reveals that certain kinase inhibitors, including Losmapimod analogs, not only block p38α MAPK enzymatic activity but also enhance its dephosphorylation by stabilizing a conformation preferred by phosphatases. This dual-action mechanism opens new avenues for inflammation and vascular research, offering a path toward more selective and potent therapeutic strategies.

• Taltirelin Acetate: Protocols and Pitfalls for Neurodegenera

  2026-08-04

  Taltirelin acetate, a selective TRHR1 agonist, drives robust neuroprotection and dopaminergic modulation in preclinical models. This article distills cutting-edge findings into actionable protocols for Parkinson’s, itch, and sleep apnea studies, with troubleshooting advice for reproducible results.

• N-MYC/eIF4G1 Axis Drives Survival in inv(16) AML: Mechanisti

  2026-08-04

  Peramangalam et al. reveal that N-MYC sustains inv(16) acute myeloid leukemia (AML) survival by regulating eIF4G1, a previously unreported oncogenic target in AML. This study elucidates how targeting the CBFβ-SMMHC fusion protein disrupts the N-MYC/eIF4G1 axis, providing a rationale for new therapeutic strategies and advancing acute myeloid leukemia research.

• CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Ce

  2026-08-03

  The CFDA SE Cell Tracer Kit addresses the need for stable, long-term fluorescent cell labeling in proliferation and lineage tracing studies. It should be used when durable, covalent cell staining is required and is not suitable for short-term or reversible labeling applications.

• Technical Guide to Hoechst 33342/PI Double Staining Kit (K22

  2026-08-03

  The Hoechst 33342/PI Double Staining Kit enables direct, fluorescence-based discrimination of viable, apoptotic, and necrotic cells by assessing chromatin condensation and membrane integrity. This kit is intended for research workflows, particularly in microscopy-based cell death analysis, and is not suitable for diagnostic or clinical applications.

15769 records 1/1052 page Next 12345 下5页 Last page